Skip to main content
Log in

Asunaprevir/daclatasvir

Various toxicities: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Haga Y, et al. Successful retreatment with sofosbuvir plus ledipasvir for cirrhotic patients with hepatitis C virus genotype 1b who discontinued the prior treatment with asunaprevir plus daclatasvir: A case series and review of the literature. Oncotarget 9: 5509-5513, No. 4, Jan 2018. Available from: URL: http://doi.org/10.18632/oncotarget.23768 - Japan

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Asunaprevir/daclatasvir. Reactions Weekly 1688, 34 (2018). https://doi.org/10.1007/s40278-018-41669-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-41669-8

Navigation